Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation - Wikidata - wikimedia - TriplyDB

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation

http://www.wikidata.org/entity/Q34175259

about

Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.

P2860

Q36777485-D05FC124-6210-47CC-AB32-5314C6889DE3

P2860

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation

http://www.wikidata.org/entity/Q34175259

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recipient pretransplant inosin ...... topoietic cell transplantation

@ast

Recipient pretransplant inosin ...... topoietic cell transplantation

@en

Recipient pretransplant inosin ...... topoietic cell transplantation

@nl

type

label

Recipient pretransplant inosin ...... topoietic cell transplantation

@ast

Recipient pretransplant inosin ...... topoietic cell transplantation

@en

Recipient pretransplant inosin ...... topoietic cell transplantation

@nl

prefLabel

Recipient pretransplant inosin ...... topoietic cell transplantation

@ast

Recipient pretransplant inosin ...... topoietic cell transplantation

@en

Recipient pretransplant inosin ...... topoietic cell transplantation

@nl

P1433

Q34175259-B2F60D0C-2FBB-46C8-8986-D9F854E47919

P1476

Q34175259-CE783F6F-5F4E-4202-9BFF-D259D911492F

P2093

Q34175259-53591B0D-489E-4F65-A672-048DA0476E57

Q34175259-61340134-BD1F-42B4-B96E-2FE3457BEA8D

Q34175259-629BCA53-124B-46E2-B949-68CE71B50F81

Q34175259-66A72708-DB2A-41E3-9041-EC71B9EB7659

Q34175259-8663E214-5C3A-46F8-BEA7-5FD1956187F3

Q34175259-AFAB9C84-9A6E-42D9-BE4D-CFD0766D3BE3

Q34175259-BB4BB387-22E5-4697-8997-85982E9E84C1

Q34175259-D7CEEB31-BD2A-431D-85B5-0B4416860C97

P2860

Q34175259-062057F0-0AA6-43FE-B5D3-6F424A53E02E

Q34175259-130EE320-688E-42DC-90F5-FA7E3BAD305C

Q34175259-133BBFFE-C9D3-4637-853C-9F3495969786

Q34175259-210115C5-31FD-4C02-8FC8-D0D3528722F2

Q34175259-37D8B51E-72C3-4F0B-BDF3-47D16A8D9C87

Q34175259-40AAA48F-07AD-46A0-94F0-88C1CAB9B3FB

Q34175259-491AF34D-4A31-4FB0-AF0B-A4E302DAC931

Q34175259-50AFCF15-BB73-4CB1-9876-D1843B6B92AC

Q34175259-52B3D431-5C39-4CCA-A784-4289AE96D5E4

Q34175259-59676977-B170-4177-AD50-15CF35D0CBA2

P304

Q34175259-FBCD427F-7A3A-4996-8B61-1C4A4A7A0D83

P31

Q34175259-D9CD2751-4D1A-42EA-A259-48EE68DD9A8F

P356

Q34175259-12B2B9FB-1F0A-40D0-8B7F-DEEFFCC0FD37

P433

Q34175259-6A4F7BE5-FA43-4743-B0F6-EFD4F6E628BD

P478

Q34175259-2BB88A03-94E0-4422-A1BF-A31289C203BF

P50

Q34175259-0D1500B7-A584-4F9D-9757-F7B683536421

Q34175259-8C01C069-B19C-4499-B7B3-FF194C4234F4

P577

Q34175259-21334690-E65F-441C-9CC9-941F6400B0F7

P698

Q34175259-49214885-1700-4D4E-8DFE-BB6EFC876D3D

P932

Q34175259-BFC1D0D5-619F-4BC1-9160-407E77D63BE7

P356

J.BBMT.2014.05.032

P1433

Biology of Blood and Marrow Transplantation

P1476

Recipient pretransplant inosin ...... topoietic cell transplantation

@en

P2093

Brian R Phillips

http://www.w3.org/2001/XMLSchema#string

Brianne S Raccor

http://www.w3.org/2001/XMLSchema#string

Haichuan Duan

http://www.w3.org/2001/XMLSchema#string

Jeannine S McCune

http://www.w3.org/2001/XMLSchema#string

Joanne Wang

http://www.w3.org/2001/XMLSchema#string

Linda J Risler

http://www.w3.org/2001/XMLSchema#string

Meagan J Bemer

http://www.w3.org/2001/XMLSchema#string

Michael J Boeckh

http://www.w3.org/2001/XMLSchema#string

P2860

Two distinct cDNAs for human IMP dehydrogenase

Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding

Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs

Characterization of human type I and type II IMP dehydrogenases

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial

Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205).

The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models.

A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning.

P304

1544-1552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2014.05.032

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Brenda M Sandmaier

P577

2014-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24923537

http://www.w3.org/2001/XMLSchema#string

P932

4163086

http://www.w3.org/2001/XMLSchema#string